EuroProxima Dimetridazole
Art. No. 5091DIME
Product info
Intended use
EuroProxima Dimetridazole is a competitive enzyme immunoassay for quantitative analysis of dimetridazole in various matrices.
General Information
Dimetridazole (DMZ) is a 5-nitroimidazole drug, traditionally used for the prevention and treatment of histomoniasis in turkeys, trichomoniasis in pigeons, genital trichomoniasis in cattle and the prevention and treatment of haemorrhagic enteritis in pigs. DMZ is listed in Annex IV of Council Regulation 2377/90/EC, and is thus banned from the use in food-producing animals.
The Dimetridazole ELISA is a competitive enzyme immunoassay based on antibodies directed against dimetridazole.
Accessories
Dear customers,
we now provide the documents for our products in an electronic format which include the Instructions for Use (IFU), Safety Data Sheets (SDS), Application notes and the Certificate of Analysis (CoA). For batches placed on the market after 1st of January 2024, you can find our documents on the eIFU portal eifu.r-biopharm.com/RBNL.
Specifications | |
---|---|
Art. No | 5091DIME |
Test format | Microtiter plate with 96 wells (12 strips with 8 wells each). |
Sample preparation | For the mentioned matrices, fast and efficient methods are included in the test kit description. |
Incubation time | 1 h 30 min |
LOD (Detection Limit) | Shrimp 0.8 ng/g (ppb), tissue 0.3 ng/g, milk 0.3 ng/ml, egg 0.3 ng/g, serum 0.3 ng/ml |
Validated matrices | Shrimp, tissue, milk, egg and serum. |
Detected analyte | Dimetridazole in shrimp, tissue, milk, egg and serum. |
Evaluation | Microtiter plate spectrophotometer (450 nm) |
Files | |
---|---|
Instructions | English |
MSDS | 5091dime.zip (English) |